Combined Treatment with Citalopram and Buspirone: Effects on Serotonin 5-HT2A and 5-HT2C Receptors in the Rat Brain
by
Syvalahti E, Penttila J, Majasuo H, Palvimaki EP, Laakso A, Hietala J.
Department of Pharmacology and Clinical Pharmacology,
University of Turku, 20520 Turku, Finland.
Pharmacopsychiatry. 2006 Jan;39(1):1-8.


ABSTRACT

INTRODUCTION: We wanted to elucidate whether the proposed advantages of citalopram-buspirone combination treatment are related to changes in 5-HT (2A/C) receptor-mediated neurotransmission. METHODS: The affinity of buspirone to 5-HT (2A) and 5-HT (2C) receptors was measured in vitro, and the influence of buspirone on 5-HT (2C) receptor-mediated phosphoinositide hydrolysis was estimated. Four groups of rats received citalopram (10 mg/kg), buspirone (6 mg/kg), citalopram-buspirone combination, or saline once a day s. c. for 14 days. Treatment effects on 5-HT (2A) and 5-HT (2C) receptors were investigated by receptor autoradiography with antagonist and agonist radioligands. RESULTS: Buspirone was found to be a weak 5-HT (2C) receptor antagonist, with a low affinity for 5-HT (2A) and 5-HT (2C) receptors. Repeated buspirone-citalopram combination treatment markedly decreased [ (3)H]ketanserin and [ (125)I]DOI binding to 5-HT (2A) receptors. Repeated administration of buspirone and buspirone-citalopram combination increased the affinity of [ (3)H]mesulergine toward 5-HT (2C) receptors, and buspirone-citalopram combination also decreased [ (125)I]DOI binding to 5-HT (2C) receptors. DISCUSSION: We suggest that downregulation of brain 5-HT (2A) receptors and possibly of 5-HT (2C) receptor agonist sites is involved in the beneficial clinical effects of buspirone-SSRI augmentation treatment. Furthermore, a conversion of brain 5-HT (2C) receptors from high- to low-affinity state may provide an additional mechanism for the anti-anxiety effects of buspirone. Abbreviations. B (max):maximum receptor density DOI:(+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane 5-HT:serotonin (5-hydroxytryptamine) IP:inositol monophosphate K(d):equilibrium dissociation constant (affinity) K(i):inhibition constant KRB:Krebs-bicarbonate PI:phosphoinositide 1-PP:1-(2-pyrimidinyl)piperazine SSRI:selective serotonin reuptake inhibitor.
OCD
SSRIs
Serotonin
Dopamine
Clomipramine
Sertraline and OCD
Dopamine and OCD
Alcohol and citalopram
Citalopram and ecstasy
SSRIs and panic disorder
Citalopram and selegiline
Citalopram v nortriptyline
Citalopram v amitriptyline
Citalopram and depression
Citalopram and panic disorder
Serotonin and romantic lovers
Citalopram and eating disorders
Big Pharma meets Madison Avenue
Citalopram (Cipramil, Celexa) : oral v intravenous


Refs
and further reading

HOME
HedWeb
Nootropics
erythroxylum-coca.com
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family